NorthWest Biotherapeutics Inc (NWBO)

[ccie1024]

LET,

"Wow... thank you"

I think you missed the point. WH specifically called our attention to the last paragraph:

“The search for effective treatment of glioblastomas in patients is still ongoing today. Immunotherapy, or treatment via recruitment of the immune system, to fight these neoplastic cells has been investigated. First encouraging results with immuno-therapeutic approaches in patients suffering from glioblastoma were obtained by Northwest Biotherapeutics using “DCVax Brain”, a cell-based vaccination approach employing patient-derived dendritic cells loaded with autologous tumor cell lysates, and by Celldex, which used a peptide from EGFRvIII for inducing antigen-specific CTL responses, which in turn correlated with prolonged median survival times compared to median survival times obtained when using standard treatment (Heimberger et al., 2006).

Interesting, encouraging, maybe nothing but old news.

On the other hand, maybe the word is getting out to an audience that needs to hear it.